Could electromagnetic waves help shrink breast tumors before surgery?

NCT ID NCT07218432

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 41 times

Summary

This pilot study is testing whether a device called TheraBionic P1, which delivers targeted electromagnetic fields, can affect breast cancer tumors before surgery. About 24 women with early-stage, hormone receptor-positive, HER2-negative breast cancer will use the device three times daily for 60 minutes each session. Researchers will measure how many cancer cells remain in the removed tumor tissue to see if the treatment has any effect.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Karmanos Cancer Institute Weisberg Cancer Treatment Center

    RECRUITING

    Farmington Hills, Michigan, 48334, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Clarkston

    RECRUITING

    Clarkston, Michigan, 48346, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Flint

    RECRUITING

    Flint, Michigan, 48532, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Greater Lansing

    RECRUITING

    Lansing, Michigan, 48910, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Lapeer Region

    RECRUITING

    Lapeer, Michigan, 48466, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Northern Michigan

    RECRUITING

    Petoskey, Michigan, 49770, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Port Huron

    RECRUITING

    Port Huron, Michigan, 48060, United States

    Contact Phone: •••-•••-••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

TheraBionic P1 device (amplitude-modulated electromagnetic fields)

What this could lead to

If it works, this could point toward a non-invasive, drug-free way to shrink breast cancer tumors before surgery.

What could go wrong

This is a very early, small pilot study with only 24 participants. It may show no effect on tumors, and the device is not a standard treatment.

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Her2-receptor negative breast cancer hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.